Answers are grounded in this paper and cite their sources.
A test-negative case-control study shows original COVID-19 vaccines reduce severe hospitalizations in Alaska Native adults, suggesting booster doses are vital as immunity wanes over time.
American Indian/Alaska Native (AI/AN) peoples experienced some of the highest rates of coronavirus disease 2019 (COVID-19) disease in the United States. However, there are limited data on COVID-19 vaccine effectiveness in this population. We performed a test-negative case‒control study using electronic health record data to evaluate the effectiveness of the original three FDA-authorised vaccines to prevent COVID-19-associated hospitalisations among AI/AN adults during 2021-2022. COVID-19 vaccines were effective in preventing COVID-19-associated hospitalisation, intensive care unit admission, mechanical ventilation and death in this population. However, vaccine effectiveness waned over time and during the post-Omicron variant time period. Booster vaccination proved effective during a period when the Omicron variant was circulating. Waning effectiveness with time and the introduction of new variants supports the need to stay up-to-date with SARS-CoV-2 vaccination. Evaluating vaccine effectiveness using electronic health records proved to be a useful tool during a pandemic.
No takes yet. Share an insight, caveat, or question.
Blake et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: